Anbio Biotechnology (NNNN)
NASDAQ: NNNN · Real-Time Price · USD
25.84
-0.04 (-0.15%)
At close: May 8, 2026, 4:00 PM EDT
26.00
+0.16 (0.62%)
After-hours: May 8, 2026, 6:47 PM EDT
Anbio Biotechnology Market Cap
Anbio Biotechnology has a market cap or net worth of $1.13 billion as of May 8, 2026. Its market cap has increased by 285.67% in one year.
Market Cap
1.13B
Enterprise Value
1.12B
1-Year Change
285.67%
Ranking
Category
Stock Price
$25.84
Market Cap Chart
Since the IPO on February 19, 2025, Anbio Biotechnology's market cap has increased from $219.46M to $1.13B, an increase of 416.80%. That is a compound annual growth rate of 287.01%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 1.13B | -14.07% |
| Dec 31, 2025 | 1.32B | 501.40% |
| Feb 19, 2025 | 219.46M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| LeMaitre Vascular | 2.47B |
| DENTSPLY SIRONA | 2.20B |
| Alamar Biosciences | 1.63B |
| AtriCure | 1.33B |
| STAAR Surgical Company | 1.32B |
| Pulse Biosciences | 1.30B |
| Kestra Medical Technologies | 1.23B |
| BioLife Solutions | 1.08B |